SRNE
Sorrento Therapeutics Inc
Price:  
0.31 
USD
Volume:  
176,993,280.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRNE EV/EBITDA

-125527.8%
Upside

As of 2024-05-25, the EV/EBITDA ratio of Sorrento Therapeutics Inc (SRNE) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SRNE's latest enterprise value is 78.19 mil USD. SRNE's TTM EBITDA according to its financial statements is -340.66 mil USD. Dividing these 2 quantities gives us the above SRNE EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 15.7x - 22.4x 19.6x
Forward P/E multiples 20.1x - 24.0x 22.6x
Fair Price (366.99) - (408.23) (385.44)
Upside -119524.9% - -132943.1% -125527.8%
0.31 USD
Stock Price
(385.44) USD
Fair Price

SRNE EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-24 -0.21
2024-05-23 -0.21
2024-05-22 -0.21
2024-05-21 -0.21
2024-05-20 -0.21
2024-05-17 -0.21
2024-05-16 -0.21
2024-05-15 -0.21
2024-05-14 -0.21
2024-05-13 -0.21
2024-05-10 -0.21
2024-05-09 -0.21
2024-05-08 -0.21
2024-05-07 -0.21
2024-05-06 -0.21
2024-05-03 -0.21
2024-05-02 -0.21
2024-05-01 -0.21
2024-04-30 -0.21
2024-04-29 -0.21
2024-04-26 -0.21
2024-04-25 -0.21
2024-04-24 -0.21
2024-04-23 -0.21
2024-04-22 -0.21
2024-04-19 -0.21
2024-04-18 -0.21
2024-04-17 -0.21
2024-04-16 -0.21
2024-04-15 -0.21